Antares Pharma Inc (ATRS)

3.01
0.02 0.67
NASDAQ : Health Care
Prev Close 2.99
Open 3.01
Day Low/High 2.95 / 3.04
52 Wk Low/High 0.67 / 2.25
Volume 1.14M
Avg Volume 1.47M
Exchange NASDAQ
Shares Outstanding 156.41M
Market Cap 467.66M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Antares Pharma Reports Second Quarter 2017 Operating And Financial Results

Antares Pharma Reports Second Quarter 2017 Operating And Financial Results

Revenue of $13.4 Million and Net Loss Per Share of $0.02

Stocks Under $10 Weekly Summary

It was a rough week for the portfolio.

Stocks Under $10 Weekly Summary

We made several trades and price target changes during a mixed week for the portfolio.

Stocks Under $10 Weekly Summary

The portfolio has some high fliers and underperformers last week as we head into the heart of earnings season.

Stocks Under $10 Weekly Summary

We brought a new name into the portfolio last week as the Fed's comments helped lift the market.

Stocks Under $10 Weekly Summary

We made no trades during the holiday-shortened week, but added to our natural hedge today.

Stocks Under $10 Weekly Summary

We added a name to the portfolio's Bullpen as a whirlwind quarter came to an end.

Stocks Under $10 Weekly Summary

We exited 2 positions and took some profits during a busy week for the portfolio.

Stocks Under $10 Weekly Summary

We initiated a new position and made several other trades during a week of twists and turns.

Stocks Under $10 Weekly Summary

We initiated 2 new positions in a week dominated by political events.

Antares Pharma Announces Debt Financing From Hercules Capital

Five Year Term Loan Agreement Provides Up To $35 Million

Stocks Under $10 Weekly Summary

We exited 3 names last week as stocks continued their run.

Interesting ATRS Put Options For July 21st

Investors in Antares Pharma Inc. saw new options begin trading this week, for the July 21st expiration.

Stocks Under $10 Weekly Summary

It was a busy week of moves in the portfolio as we head into the latter half of the second quarter.

Stocks Under $10 Weekly Summary

We initiated one new position and exited another last week, while several other names reported earnings.

Digging Into Amplify and Antares Results

BETR and ATRS report March-quarter numbers. Plus, post-call commentary on USA Technologies.

Antares Pharma Reports First Quarter 2017 Operating And Financial Results

Multiple Drug Device Combination Products Pending FDA Approval

Stocks Under $10 Weekly Summary

We add a new name to the portfolio during a busy week of earnings.

Stocks Under $10 Weekly Summary

During a busy week of earnings and data, we exited 2 positions and initiated a small one.

Don't Be Surprised If Dip Buyers Jump In on Any Pullback

Don't Be Surprised If Dip Buyers Jump In on Any Pullback

We'll see what happens in the way of reaction to Trump's tax policy this afternoon, but if we sell off I'm likely going to be a buyer.

Stocks Under $10 Weekly Summary

We exited one position and downgraded another as earnings season heated up.

Stocks Under $10 Weekly Summary

We added a new name to the portfolio as the market took a breather in a shortened trading week.

Stocks Under $10 Weekly Summary

Chris Versace runs down the portfolio.